Mometasone + Formoterol
Form: Inhaler(MDI)
Strength: 100 mcg/5 mcg , 200 mcg/5 mcg
Reference Brands: Dulera®(US)
Category: Respiratory Disorder
Mometasone + Formoterol, marketed as Dulera® in the United States, is a combination inhaler used to manage asthma in patients aged 12 years and older. It combines Mometasone furoate, an inhaled corticosteroid (ICS) that reduces airway inflammation, with Formoterol fumarate, a long-acting beta-agonist (LABA) that relaxes bronchial muscles for easier breathing. This powerful duo helps control asthma symptoms and prevent attacks. Dulera® is available in metered-dose inhaler (MDI) form in two strengths: 100 mcg/5 mcg and 200 mcg/5 mcg. Widely prescribed in the U.S., it is a key component in respiratory therapy and pharma B2B exports.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Fluticasone furoate + Vilanterol
Strength: 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol
Form: Powder For Inhalation(DPI/MDI)
Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)
View Details Get Enquiry
Ambroxol Hydrochloride
Strength: Tab: 30 mg, 60 mg; Syrup: 15 mg/5 mL, 30 mg/5 mL; Drops: 7.5 mg/mL, 15 mg/mL
Form: Tablets, Syrup & Oral drops
Reference Brands: Mucosolvan®, Flavamed®, Ambrobeta®, Ambroxol-ratiopharm®(EU)
View Details Get Enquiry
Carbocisteine
Strength: Cap: 375 mg and 750 mg; Oral Solution: 50 mg/5 mL and 750 mg/5 mL
Form: Capsules, Oral Solutions/Syrups
Reference Brands: Mucodyne, Lisomucil®, Rhinathiol®, Muciclar®, Actithiol®, Mucolex®(US)
View Details Get Enquiry
Triprolidine HCl + Pseudoephedrine HCl
Strength: Tab: 2.5 mg/60 mg; Oral Solution: 0.5 mg/mL, 0.625 mg/mL, 0.938 mg/mL, and 1.25 mg/mL
Form: Tablet & Oral solution
Reference Brands: Histex®, Vanahist PD®, M-Hist PD®, PediaClear®, Aprodine®, Zymine®, Allerfrim®, ENDAL®
View Details Get Enquiry